Manuel Cliquennois

Lille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Trends in cell collection and apheresis practices: Insights from a cross-sectional study on the use of Spectra Optia in collection and transplant centers.

Trends in cell collection and apheresis practices: Insights from a cross-sectional study on the use of Spectra Optia in collection and transplant centers.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: June 05, 2025

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.

Journal: Blood
Published: June 09, 2022

Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.

Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.

Journal: American journal of hematology
Published: April 05, 2022

Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.

Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.

Journal: Infection
Published: June 14, 2021

Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.

Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.

Journal: American journal of hematology
Published: July 03, 2019

Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.

Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.

Journal: American journal of hematology
Published: February 08, 2019

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Journal: Leukemia
Published: October 05, 2018

Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.

Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.

Journal: Blood
Published: March 23, 2016

Congenital Recessive Methemoglobinemia Revealed in Adulthood: Description of a New Mutation in Cytochrome b5 Reductase Gene.

Congenital Recessive Methemoglobinemia Revealed in Adulthood: Description of a New Mutation in Cytochrome b5 Reductase Gene.

Journal: Hemoglobin
Published: August 21, 2015

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients.

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients.

Journal: Blood
Published: October 09, 2014

Renal extramedullary hematopoietic tumor revealing a hereditary spherocytosis in an adult patient

Renal extramedullary hematopoietic tumor revealing a hereditary spherocytosis in an adult patient

Journal: La Revue de medecine interne
Published: June 27, 2014

Confirmation of a founder effect in a Northern European population of a new β-globin variant: HBB:c.23_26dup (codons 8/9 (+AGAA)).

Confirmation of a founder effect in a Northern European population of a new β-globin variant: HBB:c.23_26dup (codons 8/9 (+AGAA)).

Journal: European journal of human genetics : EJHG
Published: February 13, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026